Ablation is safer than many patients are told
For low-burden but symptomatic PVCs, ablation is generally considered safe — especially when left ventricular (LV) function is intact. Modern techniques such as pace mapping have made ablation both feasible and low-risk, even when PVCs are infrequent during the procedure.
Some advanced centers now use medication or targeted nerve stimulation to provoke PVCs that stay quiet during an EP study, which is a major advance for exactly the patients this site advocates for. Only a limited number of EPs and clinics currently offer these methods; see our Mapping Solutions page for the specific technique and evidence behind it.
Because these advanced practices remain concentrated at a handful of centers, finding an experienced doctor is essential — which is exactly why we're building a directory of specialists who treat highly symptomatic, low-burden PVCs. See Find a Specialist.
What the guidelines say
Two major guideline bodies have already moved past a strict burden cutoff for treatment decisions:
The ESC's 2022 guideline names catheter ablation as a first-line treatment for symptomatic idiopathic PVCs or VT originating from the right ventricular outflow tract or left fascicles, without requiring a minimum burden.[1]
This joint consensus statement endorses ablation for symptomatic idiopathic PVCs generally, particularly when medications fail, aren't tolerated, or simply aren't preferred by the patient.[2]
How safe and effective ablation actually is
Across multiple published studies, PVC ablation consistently shows high success rates and a low, well-characterized complication profile:
Evidence for low-burden, highly symptomatic patients
The studies above cover PVC ablation broadly. These focus specifically on patients like the ones PVC Voices advocates for — low count, high suffering:
Found that patients with fewer than 5,000 PVCs per 24 hours can still be highly symptomatic, and concluded that ablation in these cases is justified, safe, and improves quality of life.[7]
Demonstrated that ablation is feasible and effective for low-burden PVCs specifically when specialized mapping strategies are used.[8]
A recent review focused specifically on strategies for the scenario where PVCs are infrequent — directly relevant to low-burden patients.[9]
Putting it together
What the evidence supports
- Guidelines: both the ESC and HRS consensus support ablation for symptomatic idiopathic PVCs, with no burden threshold required.
- Outcomes: idiopathic PVC ablation achieves roughly 80–94% success with about 3–5% complication rates; RVOT cases see the highest success and lowest risk.
- Low burden: even patients with fewer than 5,000 PVCs per day can safely benefit from ablation when symptoms are severe, given modern mapping methods.
An honest caveat
Ablation isn't always feasible for low-burden, symptomatic PVCs. Multiple PVC origins can make localization difficult, and PVCs near the heart's natural conduction system can make ablation too risky to attempt. Only a small number of electrophysiologists at high-volume centers are willing to take on these complex cases — many others default to drug therapy, if a suitable medication can be found at all. This evidence supports pursuing treatment; it doesn't guarantee every case will find a willing, safe path to it.